MERS-CoV Antikörper
(MERS-Coronavirus (MERS-CoV))
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte MERS-CoV Kategorien
MERS-CoV Antikörper
High quality antibodies with extensive validation data.
Empfohlene MERS-CoV Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Applikation
ELISA, Neut
Validierungen
Kat. Nr.
ABIN7573665
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Applikation
ELISA, WB
Validierungen
Kat. Nr.
ABIN7573664
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Applikation
Neut, SPR, FACS
Validierungen
Kat. Nr.
ABIN7573669
Menge
100 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren MERS-CoV Produkten
: "38" in: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991): "Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. ..." in: The Lancet. Infectious diseases, (2020) (PubMed).
: "Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor." in: ACS nano, Vol. 14, Issue 4, pp. 5135-5142, (2020) (PubMed).
: "Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus." in: PLoS ONE, Vol. 14, Issue 7, pp. e0220196, (2020) (PubMed).
: "Immunogenicity of Different Forms of Middle East Respiratory Syndrome S Glycoprotein." in: Acta naturae, Vol. 11, Issue 1, pp. 38-47, (2019) (PubMed).
: "A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV." in: Viruses, Vol. 10, Issue 9, (2018) (PubMed).
: "Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S." in: Biologicals : journal of the International Association of Biological Standardization, Vol. 54, pp. 58-62, (2018) (PubMed).
: "Inclusion of MERS-spike protein ELISA in algorithm to determine serologic evidence of MERS-CoV infection." in: Journal of medical virology, Vol. 90, Issue 2, pp. 367-371, (2018) (PubMed).
: "A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein." in: Emerging microbes & infections, Vol. 6, Issue 5, pp. e37, (2017) (PubMed).
Haben Sie etwas anderes gesucht?
- MERS-Coronavirus Spike
- Merlin
- MERD
- Meprin B
- MEPE
- MEPCE
- MEP1A
- MEOX2
- MEOX1
- Meningioma 1
- Menin
- MEND
- menC
- MEMO1
- Membrane-Spanning 4-Domains, Subfamily A, Member 8
- Membrane transport protein XK
- Membrane Protein, Palmitoylated 2 (MAGUK P55 Subfamily Member 2)
- Membrane IgA
- Membralin
- MELK
- MERS-CoV Nucleocapsid
- MERTK
- MerTK/Tyro3
- MESDC1
- MESDC2
- Mesogenin 1
- Mesothelin
- Mesothelin (Amatuximab Biosimilar)
- MESP1
- Mesp2
- MEST
- MET
- MET14
- MET6
- MET8
- Meta-Pneumovirus
- Metabotropic Glutamate Receptor 1
- Metabotropic Glutamate Receptor 3
- Metabotropic Glutamate Receptor 4
- Metabotropic Glutamate Receptor 5
Sie sind hier:
